LIPOSOMAL AMPHOTERICIN-B THERAPY OF MURINE HISTOPLASMOSIS

被引:27
作者
GRAYBILL, JR [1 ]
BOCANEGRA, R [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284
关键词
D O I
10.1128/AAC.39.8.1885
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Liposomal amphotericin B (AmBisome) was compared with amphotericin B deoxycholate for the treatment of disseminated murine histoplasmosis. Liposomal amphotericin B was well tolerated and, milligram for milligram, was as potent as amphotericin B deoxycholate.
引用
收藏
页码:1885 / 1887
页数:3
相关论文
共 19 条
[1]   TRANSFER OF PROTECTIVE IMMUNITY IN MURINE HISTOPLASMOSIS BY A CD4+ T-CELL CLONE [J].
ALLENDOERFER, R ;
MAGEE, DM ;
DEEPE, GS ;
GRAYBILL, JR .
INFECTION AND IMMUNITY, 1993, 61 (02) :714-718
[2]   COMPARISON OF THE INVITRO ANTIFUNGAL ACTIVITY OF FREE AND LIPOSOME-ENCAPSULATED AMPHOTERICIN-B [J].
ANAISSIE, E ;
PAETZNICK, V ;
PROFFITT, R ;
ADLERMOORE, J ;
BODEY, GP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (08) :665-668
[3]   AMPHOTERICIN-B - DELIVERY SYSTEMS [J].
BRAJTBURG, J ;
POWDERLY, WG ;
KOBAYASHI, GS ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :381-384
[4]   TREATMENT OF SYSTEMIC MYCOSES WITH KETOCONAZOLE - EMPHASIS ON TOXICITY AND CLINICAL-RESPONSE IN 52 PATIENTS [J].
DISMUKES, WE ;
STAMM, AM ;
GRAYBILL, JR ;
CRAVEN, PC ;
STEVENS, DA ;
STILLER, RL ;
SAROSI, GA ;
MEDOFF, G ;
GREGG, CR ;
GALLIS, HA ;
FIELDS, BT ;
MARIER, RL ;
KERKERING, TA ;
KAPLOWITZ, LG ;
CLOUD, G ;
BOWLES, C ;
SHADOMY, S .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :13-20
[5]   THERAPEUTIC EVALUATION OF FREE AND LIPOSOME-ENCAPSULATED AMPHOTERICIN-B IN THE TREATMENT OF SYSTEMIC CANDIDIASIS IN MICE [J].
GONDAL, JA ;
SWARTZ, RP ;
RAHMAN, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1544-1548
[6]  
GRAYBILL JR, 1985, ANN INTERN MED, V103, P861
[7]   EFFICACY OF ESCALATING DOSES OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) AGAINST HEMATOGENOUS CANDIDA-LUSITANIAE AND CANDIDA-KRUSEI INFECTION IN NEUTROPENIC MICE [J].
KARYOTAKIS, NC ;
ANAISSIE, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2660-2662
[8]   LIPOSOMES AS CARRIERS OF ANTIMICROBIAL AGENTS [J].
LOPEZBERESTEIN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :675-678
[9]   LIPOSOMAL AMPHOTERICIN-B (AMBISOME) - SAFETY DATA FROM A PHASE-II/III CLINICAL-TRIAL [J].
MEUNIER, F ;
PRENTICE, HG ;
RINGDEN, O .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :83-91
[10]   PREVENTION OF RELAPSE OF HISTOPLASMOSIS WITH FLUCONAZOLE IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
NORRIS, S ;
WHEAT, J ;
MCKINSEY, D ;
LANCASTER, D ;
KATZ, B ;
BLACK, J ;
DRIKS, M ;
BAKER, R ;
ISRAEL, K ;
TRAEGER, D ;
MORIARITY, S ;
FRAIZ, J ;
WEBB, D ;
SLAMA, T .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (06) :504-508